• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Angina Pectoris

Angina Pectoris - 423 Studies Found

Completed : REDUCER-I: An Observational Study of the Neovasc Reducer™ System
:
  • Angina Pectoris
  • Angina Pectoris, S
    : 2016-03-11
    : Device: Neovasc Reducer System An aid in the management of chronic refractory angina pectoris
Completed : Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
:
  • Coronary Artery Disease
  • Angina Pectoris

: 2011-09-22
:
  • Drug: Ranolazine

Active, not recruiting : Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods
:
  • Angina Pectoris
  • Left Ventricular Wall Motion Abnormalities

  • : 2013-08-29
    :
    • Device: Cardiac ultrasound Pat

Terminated : Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
:
  • Chest Pain
  • Stable Angina Pectoris, CCS Class I to III
  • : 2010-12-15
    :
    • Device: CCTA Complete diagnost

Terminated : Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
:
  • Stable Angina Pectoris
  • Unstable Angina Pe
    : 2009-08-07
    : Device: TAXUS Liberté paclitaxel-eluting coronary stent system diameter is 2.5mm
Completed : Clinical Impact of the Withdrawal of Nitrate in Patients With Stable Angina
:
  • Stable Angina
  • Myocardial Ischemia
  • Drug: Nitrate Two arms: placeb

Terminated : Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy
:
  • Angina Pectoris
  • Silent Ischemia

: 2009-07-22
:
  • Drug: Clopidogrel 300-600 load

Completed : Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
:
  • Hypertension
  • Hypercholesterolemia
  • An
    : 2010-08-05
    : Drug: Caduet One Caduet tablet will be administered once daily after breakfast, in principle, for 52 wee
Terminated : COBRA SHIELD OCT Study
: Stable Angina
: 2014-08-19
:
  • Drug: Aspirin 75-325 mg q.d. a

Withdrawn : Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
:
  • Peripheral Arterial Disease
  • Angina

: 2008-04-08
:
  • Drug: Ranolazine 500mg tablet

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.